Puma Biotechnology, Inc.
(NASDAQ : PBYI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.99%185.251.3%$523.93m
ARRYArray BioPharma Inc.
0.38%46.388.1%$429.46m
CELGCelgene Corporation
-5.42%93.551.3%$409.28m
GILDGilead Sciences, Inc.
-0.84%68.800.9%$404.61m
BIIBBiogen Inc.
-1.48%235.561.3%$375.28m
ILMNIllumina, Inc.
-0.76%358.833.5%$305.53m
REGNRegeneron Pharmaceuticals, Inc.
-2.66%311.762.6%$245.40m
VRTXVertex Pharmaceuticals Incorporated
-1.65%180.931.9%$225.13m
ALXNAlexion Pharmaceuticals, Inc.
-4.27%126.742.0%$202.53m
EXASExact Sciences Corporation
-1.12%114.3624.1%$195.09m
AAgilent Technologies, Inc.
-0.44%73.021.6%$181.42m
BMRNBioMarin Pharmaceutical Inc.
-2.61%85.624.3%$129.71m
INCYIncyte Corporation
-2.19%86.762.5%$116.09m
SRPTSarepta Therapeutics, Inc.
-1.42%128.0314.7%$112.77m
MRTXMirati Therapeutics Inc.
0.15%101.592.5%$102.13m

Company Profile

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.